Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Prognostic significance of baseline reverse transcriptase polymerase chain reaction for prostate specific antigen (RT-PCR PSA) and RT-PCR PSA “responses” in men with hormone refractory prostate cancer treated with chemotherapy

Ross RW, Manola J, Hennessy K, Galsky M, Scher H, Small EJ, Kelly WK, Kantoff PW. Prognostic significance of baseline reverse transcriptase polymerase chain reaction for prostate specific antigen (RT-PCR PSA) and RT-PCR PSA “responses” in men with hormone refractory prostate cancer treated with chemotherapy. Proc ASCO. 2005.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.